Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,885 across all filing types
Latest filing 2020-08-14 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled as a board meeting announcement and contains detailed content about the company's Investor Relations Management System, including principles, organizational structure, communication methods, and archival procedures. It is a policy or governance document passed at a board meeting, not a financial report or earnings release. There is no indication of financial data, audit information, or voting results. The document focuses on governance practices related to investor relations management, which fits the Governance Information category. The document length is 4543 characters, which is sufficient for a substantive governance report rather than a brief announcement. Therefore, the most appropriate classification is Governance Information (CGR).
2020-08-14 Chinese
2020年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "九芝堂股份有限公司 2020 年半年度财务报告" which translates to "Jiuzhitang Co., Ltd. 2020 Semi-Annual Financial Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2020. The report explicitly states it is a half-year report and includes comprehensive financial data and analysis for the period. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-08-14 Chinese
2020年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "九芝堂股份有限公司 2020 年半年度报告全文" which translates to "Jiuzhitang Co., Ltd. 2020 Semi-Annual Report Full Text." It contains detailed financial data, business overview, management discussion and analysis, and operational details for the first half of 2020 (January 1 to June 30, 2020). The content includes financial metrics, business segments, R&D projects, marketing strategies, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. The presence of actual financial data and substantive analysis confirms it is a financial report for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-08-14 Chinese
第七届董事会第二十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is titled as a board meeting announcement and details resolutions passed at the Seventh Board of Directors' 23rd meeting. It includes voting results on various company matters such as approval of the 2020 semi-annual report, renaming of an audit department, senior management remuneration plans, and adoption of internal management systems. The document does not contain the full semi-annual report itself but references it as published elsewhere (with announcement numbers). The content focuses on board decisions and governance matters rather than financial statements or earnings data. Therefore, this document is best classified as Board/Management Information (MANG). The document length is short (2476 characters), consistent with a meeting announcement rather than a full report.
2020-08-14 Chinese
内部审计管理制度
Governance Information Classification · 95% confidence The document is titled as an announcement from the company's board meeting and contains detailed internal audit management system rules, including the structure, responsibilities, procedures, and authority of the internal audit department. It is a formal internal governance document passed by the board. It does not contain financial statements or audit results but rather sets out the internal audit policies and procedures. It is not a full annual report, audit report, or financial report. It is also not a brief announcement or a certification. The content fits best under Governance Information (CGR), as it details the company's internal rules and governance practices related to internal audit.
2020-08-14 Chinese
关于并购基金的投资进展公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "临时公告" (temporary announcement) and is about the investment progress of an acquisition fund related to the company 九芝堂股份有限公司. It details the background, current status, and supplementary agreement regarding the investment in Stemedica Cell Technologies Inc. The document includes specific financial figures and contractual terms but does not contain comprehensive financial statements or detailed financial performance data. It is an update on a capital investment transaction rather than a full financial report or earnings release. The document length is 3567 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under the category of Capital/Financing Update (CAP), as it provides updates on company fundraising and investment activities.
2020-08-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.